GetTopicDetailResponse(id=74f0598066f, topicName=晚期三陰性乳腺癌, introduction=晚期三陰性乳腺癌, content=null, image=null, comments=5, allHits=1251, url=https://h5.medsci.cn/topic?id=59806, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=74099, tagList=[TagDto(tagId=74099, tagName=晚期三陰性乳腺癌)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1927278, encodeId=eab3192e27821, content=<a href='/topic/show?id=74f0598066f' target=_blank style='color:#2F92EE;'>#晚期三陰性乳腺癌#</a>, objectTitle=Clin Cancer Res：法米替尼、卡瑞利珠單抗和nab-紫杉醇聯(lián)合治療晚期三陰性乳腺癌, objectType=article, longId=301566, objectId=a12430156640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a12430156640, replyNumber=0, likeNumber=116, createdTime=2022-09-14, rootId=0, userName=yankaienglish, userId=8ebc122, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a12430156640, moduleTitle=Clin Cancer Res：法米替尼、卡瑞利珠單抗和nab-紫杉醇聯(lián)合治療晚期三陰性乳腺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a12430156640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927277, encodeId=8212192e27775, content=<a href='/topic/show?id=74f0598066f' target=_blank style='color:#2F92EE;'>#晚期三陰性乳腺癌#</a>, objectTitle=Clin Cancer Res：Lacnotuzumab聯(lián)合吉西他濱-卡鉑治療晚期三陰性乳腺癌, objectType=article, longId=221752, objectId=5171221e521f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5171221e521f, replyNumber=0, likeNumber=152, createdTime=2022-10-15, rootId=0, userName=yankaienglish, userId=8ebc122, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5171221e521f, moduleTitle=Clin Cancer Res：Lacnotuzumab聯(lián)合吉西他濱-卡鉑治療晚期三陰性乳腺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5171221e521f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927276, encodeId=3d3c192e27628, content=<a href='/topic/show?id=74f0598066f' target=_blank style='color:#2F92EE;'>#晚期三陰性乳腺癌#</a>, objectTitle=AACR19：晚期三陰性乳腺癌患者經(jīng)Ipatasertib與Tecentriq聯(lián)合化療的ORR高達73％, objectType=article, longId=163455, objectId=500616345538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=500616345538, replyNumber=0, likeNumber=94, createdTime=2019-10-26, rootId=0, userName=yankaienglish, userId=8ebc122, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=500616345538, moduleTitle=AACR19：晚期三陰性乳腺癌患者經(jīng)Ipatasertib與Tecentriq聯(lián)合化療的ORR高達73％, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=500616345538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927274, encodeId=c8c5192e27468, content=<a href='/topic/show?id=74f0598066f' target=_blank style='color:#2F92EE;'>#晚期三陰性乳腺癌#</a>, objectTitle=袁芃教授：晚期三陰性乳腺癌內(nèi)科治療進展（一）, objectType=article, longId=136750, objectId=dacf136e50e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dacf136e50e9, replyNumber=0, likeNumber=106, createdTime=2018-04-28, rootId=0, userName=yankaienglish, userId=8ebc122, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dacf136e50e9, moduleTitle=袁芃教授：晚期三陰性乳腺癌內(nèi)科治療進展（一）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dacf136e50e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927275, encodeId=ca5e192e27575, content=<a href='/topic/show?id=74f0598066f' target=_blank style='color:#2F92EE;'>#晚期三陰性乳腺癌#</a>, objectTitle=袁芃教授：晚期三陰性乳腺癌內(nèi)科治療進展（二）, objectType=article, longId=137223, objectId=768b13e22365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=768b13e22365, replyNumber=0, likeNumber=103, createdTime=2019-03-25, rootId=0, userName=yankaienglish, userId=8ebc122, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=768b13e22365, moduleTitle=袁芃教授：晚期三陰性乳腺癌內(nèi)科治療進展（二）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=768b13e22365)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
